Showing results (391-400 of 454) with videos related to

Sort By:
Pageof 46
Lupus|September 30, 2003
Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placeboV Strand, C Aranow, M H Cardiel, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 1999
Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMCM Linker-Israeli, M Honda, R Nand, et al.
The Journal of Investigative Dermatology|November 1, 1994
Systemic lupus erythematosus: considerations for a genetic approachJ B Harley, P Sheldon, B Neas, et al.
International Journal of Cancer|August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacyT M Behr, S Memtsoudis, R M Sharkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibodyD M Goldenberg, J A Horowitz, R M Sharkey, et al.
JAMA|August 5, 1983
Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imagingD M Goldenberg, F H DeLand, S J Bennett, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1989
Correlates of preoperative hematocrit value in patients undergoing coronary artery bypassJ R Utley, D J Wallace, M E Thomason, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1989
Preoperative correlates of impaired wound healing after saphenous vein excisionJ R Utley, M E Thomason, D J Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignanciesT M Behr, B Wörmann, M Gramatzki, et al.
Pageof 46